Prestige Consumer Healthcare
PBH
#4250
Rank
S$3.46 B
Marketcap
S$72.01
Share price
-0.37%
Change (1 day)
-32.86%
Change (1 year)

P/S ratio for Prestige Consumer Healthcare (PBH)

P/S ratio as of April 2026 (TTM): 2.46

According to Prestige Consumer Healthcare's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.48. At the end of 2025 the company had a P/S ratio of 2.73.

P/S ratio history for Prestige Consumer Healthcare from 2005 to 2025

PS ratio at the end of each year

Year P/S ratio Change
20252.73-21.23%
20243.4729.42%
20232.68-4.22%
20222.80-2.68%
20212.8757.36%
20201.83-14.52%
20192.1432.3%
20181.61-29.68%
20172.30-29.3%
20163.25-5.72%
20153.4426.98%
20142.71-10.89%
20133.0479.63%
20121.6920.28%
20111.41-26.67%
20101.9244.81%
20091.33-19.62%
20081.6543.07%
20071.15-43.19%
20062.03-4.25%
20052.12

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Johnson & Johnson
JNJ
6.11 148.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Procter & Gamble
PG
3.99 62.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
5.24 113.05%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
2.44-0.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
3.90 58.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
1.91-22.17%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
0.2504-89.82%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
2.66 8.28%๐Ÿ‡ฌ๐Ÿ‡ง UK
Rite Aid
RAD
0.0016-99.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
2.64 7.48%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel